Retailer of automotive replacement parts, AutoZone (AZO), Tuesday reported a 10% growth in second-quarter earnings to $11.49 per share, helped by tax benefits. Revenue for the quarter, meanwhile, increased 1.6% to $2.5 billion.
The results came in above the expectations set by Wall Street. Analysts, on an average, had projected earnings of earnings of $9.97 per share on revenues of $2.45 billion.
Domestic same-store sales improved by 2.6% during the quarter.
CEO Bill Rhodes said, “Our industry fundamentals remain strong, and we continue to be excited about the initiatives we have underway to further enhance our inventory availability, to continue to accelerate Commercial and to meet our customers how, when and where they want to be met with our omnichannel efforts.”
The company’s inventory increased 5.4% over the same period last year, driven by new stores and increased product placement, partially offset by the sale of two businesses completed in the prior year.
Gross profit, as a percentage of sales, was 54.1%, higher than 52.9% for the same period last year, primarily due to the sale of two businesses last year.
AZO shares have been on a gaining streak since the beginning of the year and have increased about 6% so far, outperforming both the sector and the broader market. AZO is currently trading near an all-time high.
Last week, rival firm Advance Auto Parts (AAP) had reported a 52% growth in its fourth-quarter earnings to $1.17 per share, supported by a further strong increase in comparable sales.
Earnings Calendar: Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!
Most Popular
CVX Earnings: Chevron reports lower revenue and profit for Q1 2024
Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or
ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was
Comments